Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 perioperative trial of Ivonescimab plus S-1 and oxaliplatin (SOX) for locally advanced gas…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update indicates that TH9619 is being studied in a Phase 1/2 trial for advanced solid tumors, with recruitment ongoing a…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer [NA]
A prospective, single-arm exploratory trial evaluating TAS-102 (trifluridine/tipiracil) in combination with apatinib as third-line therapy f…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) [Phase 3]
This Phase 3 clinical trial compares 4 months vs 6 months of XELOX chemotherapy for gastric cancer; the study is currently active but not re…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BOLD-100 in combination with FOLFOX for advanced solid tumors, including colorectal cancer, pancreatic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer [Phase 3]
A Phase 3 randomized trial compares adjuvant oxaliplatin plus S-1 versus docetaxel plus S-1 for stage III gastric cancer; recruitment is ong…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal Cancer
The study reports completion of a clinical trial focused on management strategies for patients with cirrhosis and esophagogastric varices wh…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: MRinRT: Swansea University and SWWCC Collaboration Study.
The MRinRT Swansea University and SWWCC collaboration study updates on MRI-guided adaptive radiotherapy and is not yet recruiting, with mult…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigates IBI363 plus bevacizumab with or without nab-paclitaxel as second-line treatment for advanced gastric…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors [Phase 1]
Phase 1 clinical trial update for a CEA-targeting CAR-T therapy (PTC13) in CEA-positive advanced malignant solid tumors, currently recruitin…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Prolonged Extubation in Gastric Cancer With OSA
This ClinicalTrials.gov entry describes an ongoing, invitation-only trial investigating prolonged extubation in patients with gastric cancer…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: First in Human Study of QLS5316 in Solid Tumors [Phase 1]
This is a first-in-human Phase 1 trial of QLS5316 in various solid tumors; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating OCT-598 in patients with advanced solid tumors; the study is currently recruiting and includes multiple tu…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
A Zhejiang University-sponsored clinical trial (NCT07359586) is currently recruiting to evaluate laryngopharyngeal injury after endotracheal…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating a PD-1 antibody in combination with chemotherapy or targeted therapy, followed by a surgery-centric local …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [EARLY_Phase 1]
An early-phase (Phase 1) study evaluating pucotenlimab in combination with lenvatinib and the SOX regimen versus SOX alone in HER2-negative …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating olanzapine for cancer-associated appetite loss in patients with advanced esophageal, gastric, colorec…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cabozantinib plus durvalumab with or without tremelimumab in patients with gastroesophageal cancer and o…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2) [Phase 2]
A Phase 2 trial (VIKTORY-2) is evaluating the combination of savolitinib and durvalumab in MET-amplified advanced gastric cancer and is curr…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of combining Camrelizumab with Apatinib in patients with gastric cancer and g…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
A clinical trial is evaluating biomarkers PD-L1, tumor mutational burden, MSI, and ctDNA to predict and monitor response to immunotherapy in…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lead-212 PSV359 Therapy for Patients With Solid Tumors [Phase 1, Phase 2]
Perspective Therapeutics reports that Lead-212 PSV359 Therapy is being studied in Phase 1/2 trials for multiple solid tumors and is currentl…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers [Phase 1, Phase 2]
A Phase 1/2 feasibility trial evaluating the LUM Imaging System for detection of colorectal, pancreatic, esophageal, and gastric cancers is …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
This clinical trial update describes the collection of tissue and blood from patients with benign and malignant tumors of the soft tissue an…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: SL-28 for Advanced Solid Tumours [Phase 1, Phase 2]
Clinical trial update for SL-28 in advanced solid tumours across multiple indications; the Phase 1/Phase 2 study is currently not yet recrui…